Coming Soon
Find comprehensive information on Ovarian Cystadenoma including symptoms, diagnosis, treatment, and ICD-10 codes. This resource covers clinical documentation requirements for ovarian cysts, serous cystadenoma, mucinous cystadenoma, and pathology reports. Learn about the differential diagnosis of ovarian cystadenoma and best practices for healthcare professionals involved in the coding and billing of this condition. Explore reliable medical information for accurate clinical documentation and appropriate medical coding.
Also known as
Benign neoplasm of ovary
Non-cancerous growths or tumors in the ovary.
Ovarian cyst
Fluid-filled sacs within or on the surface of an ovary.
Serous cystadenoma of ovary
Benign ovarian tumor filled with watery fluid.
Mucinous cystadenoma of ovary
Benign ovarian tumor filled with thick, sticky fluid.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the ovarian cystadenoma serous?
When to use each related code
| Description |
|---|
| Benign ovarian cyst, glandular |
| Ovarian teratoma (dermoid cyst) |
| Endometrioma (chocolate cyst) |
Incorrect coding of laterality (right, left, bilateral) for ovarian cystadenoma can impact reimbursement and data accuracy.
Misclassifying a borderline ovarian tumor as a benign cystadenoma can lead to underreporting of severity and incorrect treatment.
Failure to distinguish between serous and mucinous cystadenoma types can affect statistical analysis and research data.
Q: How can I differentiate between a simple ovarian cystadenoma and a borderline ovarian tumor on imaging, and what are the key radiological features to look for?
A: Differentiating a simple ovarian cystadenoma from a borderline ovarian tumor (BOT) on imaging can be challenging. Simple cystadenomas typically appear as unilocular, thin-walled cysts with no solid components or papillary projections. Key radiological features suggestive of a simple cystadenoma include anechoic fluid on ultrasound and homogenous low attenuation on CT. In contrast, BOTs may exhibit thicker walls, septations, papillary projections, or solid areas. While imaging can provide valuable information, definitive diagnosis requires histopathological evaluation. Consider implementing a standardized imaging protocol for ovarian masses, incorporating both ultrasound and CT/MRI when needed, to aid in accurate characterization. Explore how the latest imaging guidelines can improve your diagnostic accuracy for ovarian tumors. Learn more about the role of MRI in characterizing complex ovarian masses.
Q: What are the recommended management strategies for postmenopausal women diagnosed with a large (>5cm), asymptomatic serous ovarian cystadenoma, considering the risk of malignancy?
A: Managing large (>5cm) asymptomatic serous ovarian cystadenomas in postmenopausal women requires careful consideration of the risk of malignancy, even if seemingly benign on imaging. Due to the increased risk of malignancy in this demographic, surgical intervention, typically laparoscopic cystectomy or oophorectomy, is often recommended. This allows for thorough histopathological examination to definitively exclude malignancy. While conservative management with serial imaging may be considered in select cases with low suspicion based on imaging characteristics and tumor markers, the risk of occult malignancy often outweighs the benefits. Consider implementing a shared decision-making approach, discussing the risks and benefits of surgical versus conservative management with the patient. Explore how current guidelines address the management of adnexal masses in postmenopausal women.
Patient presents with complaints possibly indicative of ovarian cystadenoma. Presenting symptoms include (but are not limited to) pelvic pain, abdominal bloating, abdominal distension, andor palpable ovarian mass. Differential diagnoses considered include other ovarian cysts (e.g., dermoid cyst, endometrioma), polycystic ovary syndrome (PCOS), and ovarian neoplasms. Pelvic examination reveals a unilateral or bilateral adnexal mass, possibly mobile and non-tender. Imaging studies (e.g., transvaginal ultrasound, pelvic MRI, CT scan) were ordered and demonstrate a cystic lesion on the ovary with characteristics suggestive of a cystadenoma, such as thin walls, anechoic or hypoechoic fluid content, and absence of solid components. Laboratory tests including a complete blood count (CBC), comprehensive metabolic panel (CMP), and CA-125 tumor marker may be performed to assess overall health and aid in the evaluation. Based on the clinical presentation, imaging findings, and laboratory results, a diagnosis of ovarian cystadenoma is suspected. Treatment options including watchful waiting with serial imaging, surgical excision (e.g., laparoscopy, laparotomy), or aspiration may be considered depending on the size, symptoms, and patient's preferences. Risks and benefits of each treatment option were discussed with the patient. Patient education provided on ovarian cysts, cystadenoma symptoms, treatment options, and potential complications. Follow-up appointment scheduled for reassessment and monitoring. ICD-10 code I84.1 (benign neoplasm of ovary) is considered. Medical billing codes may include CPT codes for the evaluation and management (E/M) visit, imaging studies, and surgical procedures if performed.